^
Association details:
Evidence:
Evidence Level:
Resistant: C4 – Case Studies
New
Title:

Identification of STRBP as a Novel JAK2 Fusion Partner Gene in a Young Adult With Philadelphia Chromosome-Like B-Lymphoblastic Leukemia

Published date:
01/11/2021
Excerpt:
Ph-like ALL proved refractory to traditional induction chemotherapy combined with ruxolitinib...a novel STRBP-JAK2 gene fusion in a Ph-like ALL patient with a very aggressive disease course, which proved resistant to chemotherapy combined with ruxolitinib
DOI:
10.3389/fonc.2020.611467